Connect Biopharma Holdings Ltd. (CNTB)
0.8022
-0.03
(-3.97%)
USD |
NASDAQ |
Oct 30, 16:00
0.80
0.00 (0.00%)
After-Hours: 20:00
Connect Biopharma Holdings Cash from Operations (Quarterly) : -16.19M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.19M |
| March 31, 2026 | -16.00M |
| December 31, 2025 | -11.60M |
| Date | Value |
|---|---|
| September 30, 2025 | -17.70M |
| June 30, 2025 | -12.66M |
| March 31, 2025 | -9.959M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -9.096M |
| Vaxcyte, Inc. | -232.47M |
| Foghorn Therapeutics, Inc. | -17.84M |
| Caribou Biosciences, Inc. | -22.79M |
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.456M |
| Cash from Financing (Quarterly) | 1.484M |
| Free Cash Flow | -61.54M |
| Free Cash Flow Per Share (Quarterly) | -0.2574 |
| Free Cash Flow to Equity (Quarterly) | -16.09M |
| Free Cash Flow to Firm (Quarterly) | -16.19M |
| Free Cash Flow Yield | -132.7% |